ESTRO 2022 - Abstract Book

S84

Abstract book

ESTRO 2022

Conclusion An existing prediction model for 2-year mortality in lung cancer patients, based on the predictive factors GTV and MHD, was externally validated in esophageal cancer patient cohorts. Separate updated models for dCRT and nCRT in esophageal cancer were developed. The additional analyses support the existence of an independent effect of MHD on 2-year mortality.

OC-0110 Acute cardiac effects after chemoradiotherapy in esophageal cancer patients - a prospective study

M.M.A. Søndergaard 1 , M. Nordsmark 2 , K.M. Nielsen 3 , S.H. Poulsen 3

1 Aarhus University Hospital , Department of Cardiology , Aarhus N, Denmark; 2 Aarhus University Hospital , Oncology, Aarhus N, Denmark; 3 Aarhus University Hospital, Cardiology, Aarhus N, Denmark Purpose or Objective Myocardial dysfunction, congestive heart failure and impaired physical performance may be a consequence of chemoradiotherapy (CRT) in patients with esophageal cancer (EC). The aim was to investigate left ventricular (LV) function at rest and at peak exercise by advanced echocardiography (ECHO) before and after completed CRT and additionally examine the potential alterations in peak cardiopulmonary exercise capacity by oxygen consumption assessment.

Materials and Methods